Cargando…
Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects
Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Recently, we reported that NO-NIF has potential as a...
Autores principales: | Ishizawa, Keisuke, Izawa-Ishizawa, Yuki, Yamano, Noriko, Urushihara, Maki, Sakurada, Takumi, Imanishi, Masaki, Fujii, Shoko, Nuno, Asami, Miyamoto, Licht, Kihira, Yoshitaka, Ikeda, Yasumasa, Kagami, Shoji, Kobori, Hiroyuki, Tsuchiya, Koichiro, Tamaki, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904885/ https://www.ncbi.nlm.nih.gov/pubmed/24489716 http://dx.doi.org/10.1371/journal.pone.0086335 |
Ejemplares similares
-
Abstract: Topical Application of Nitrosonifedipine, a Novel Free Radical Scavenger, Ameliorate the Ischemic Skin Flap Necrosis
por: Fukunaga, Yutaka, et al.
Publicado: (2016) -
Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction
por: Ikeda, Yasumasa, et al.
Publicado: (2014) -
Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes
por: Ikeda, Yasumasa, et al.
Publicado: (2012) -
Deletion of Hypoxia-Inducible Factor-1α in Adipocytes Enhances Glucagon-Like Peptide-1 Secretion and Reduces Adipose Tissue Inflammation
por: Kihira, Yoshitaka, et al.
Publicado: (2014) -
Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis
por: Horinouchi, Yuya, et al.
Publicado: (2018)